Leyla Bojanini

Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia

Vivek Kumar, Sikander Ailawadhi, Leyla Bojanini et al. · Blood Cancer Journal · 2019 · 73 citations · Full text

Medicine, Oncology, Cancer Epidemiology +15

A Phase I Study to Assess the Safety and Pharmacokinetics of Single-agent Lorvotuzumab Mertansine (IMGN901) in Patients with Relapsed and/or Refractory CD–56-positive Multiple Myeloma

Sikander Ailawadhi, Kevin R. Kelly, Robert Vescio et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 64 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

Timeliness of Initial Therapy in Multiple Myeloma: Trends and Factors Affecting Patient Care

Vivek Kumar, Muhamad Alhaj Moustafa, Leyla Bojanini et al. · JCO Oncology Practice · 2020 · 27 citations · Full text

Medicine, Oncology, Cancer Control +13

Racial/ethnic differences in patients with anemia and folate deficiency

Miguel González-Vélez, Carolyn Mead‐Harvey, Heidi Kosiorek et al. · International Journal of Laboratory Hematology · 2020 · 17 citations

Public Health, Hematology, Nutritional Sciences +17

Outcomes of Hepatosplenic T-Cell Lymphoma: The Mayo Clinic Experience

Leyla Bojanini, Liuyan Jiang, Alexander J. Tun et al. · Clinical Lymphoma Myeloma & Leukemia · 2020 · 16 citations

Medicine, Hematology, Oncology +10